Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Stern

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|August 10, 2004
Use of adenoviruses encoding CD40L or IL-2 against B cell lymphomaEl Kahina Meziane, Tapan Bhattacharyya, Anne C Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasiaUrsula Winters, Sai Daayana, John T Lear, et al.
Cancer Research|January 25, 2003
Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British womenEmma J Davidson, Judith A Davidson, Jane C Sterling, et al.
Cancer Research|December 7, 2007
Epithelial-mesenchymal transition events during human embryonic stem cell differentiationAngela M Eastham, Helen Spencer, Francesca Soncin, et al.
Cancer Gene Therapy|October 19, 2002
Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteinsKevin A Myers, Matthew G Ryan, Peter L Stern, et al.
Molecular Cancer Therapeutics|December 17, 2002
Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumorsKate Mulryan, Matthew G Ryan, Kevin A Myers, et al.
The Biochemical Journal|May 11, 2002
Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancerAndrew M Woods, Who W Wang, David M Shaw, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitopeAnne C Armstrong, Said Dermime, Christopher G Allinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinomaChristy Ralph, Eyad Elkord, Deborah J Burt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 11, 2012
5T4 glycoprotein regulates the sensory input-dependent development of a specific subtype of newborn interneurons in the mouse olfactory bulbSei-ichi Yoshihara, Hiroo Takahashi, Nobushiro Nishimura, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|August 10, 2004
Use of adenoviruses encoding CD40L or IL-2 against B cell lymphomaEl Kahina Meziane, Tapan Bhattacharyya, Anne C Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasiaUrsula Winters, Sai Daayana, John T Lear, et al.
Cancer Research|January 25, 2003
Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British womenEmma J Davidson, Judith A Davidson, Jane C Sterling, et al.
Cancer Research|December 7, 2007
Epithelial-mesenchymal transition events during human embryonic stem cell differentiationAngela M Eastham, Helen Spencer, Francesca Soncin, et al.
Cancer Gene Therapy|October 19, 2002
Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteinsKevin A Myers, Matthew G Ryan, Peter L Stern, et al.
Molecular Cancer Therapeutics|December 17, 2002
Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumorsKate Mulryan, Matthew G Ryan, Kevin A Myers, et al.
The Biochemical Journal|May 11, 2002
Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancerAndrew M Woods, Who W Wang, David M Shaw, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitopeAnne C Armstrong, Said Dermime, Christopher G Allinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinomaChristy Ralph, Eyad Elkord, Deborah J Burt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 11, 2012
5T4 glycoprotein regulates the sensory input-dependent development of a specific subtype of newborn interneurons in the mouse olfactory bulbSei-ichi Yoshihara, Hiroo Takahashi, Nobushiro Nishimura, et al.
Pageof 9